Author: Richens A.
Publisher: Elsevier
ISSN: 0920-1211
Source: Epilepsy Research, Vol.45, Iss.1, 2001-05, pp. : 43-47
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Proof of efficacy trials: crossover versus parallel-group studies
By Johnson T.
Epilepsy Research, Vol. 45, Iss. 1, 2001-05 ,pp. :
Proof of efficacy trials: endpoints
By French J.A.
Epilepsy Research, Vol. 45, Iss. 1, 2001-05 ,pp. :
Proof of efficacy trials: choosing the dose
By Schwabe S.
Epilepsy Research, Vol. 45, Iss. 1, 2001-05 ,pp. :
Proof of efficacy trials: seizure types
Epilepsy Research, Vol. 45, Iss. 1, 2001-05 ,pp. :
Proof of efficacy trials: seizure types
By Schmidt D.
Epilepsy Research, Vol. 45, Iss. 1, 2001-05 ,pp. :